Phytochemicals targeting Alzheimers disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action
Things like stress, lack of sleep, poor diet, alcohol, smoking, and pollution speed up that depletion
Summary measures and synthesis of results The principal summary outcome was the relative risk (RR) of several GI adverse events in people with overweight or obesity receiving treatment with GLP-1 RA, including nausea, vomiting, diarrhea, constipation, abdominal distension, upper abdominal pain, abdominal pain, abdominal discomfort, gastroesophageal reflux disease, (GERD), eructation, flatulence, decreased appetite, cholelithiasis, gallstone-related, cholecystitis, acute cholecystitis, acute pancreatitis, viral gastroenteritis, hard feces, and infrequent bowel movements
One of the studies was done on the elderly which showed a reduction in physical and mental fatigue
These drugs are also being tested to treat other conditions, and the FDA has just approved a new use for Wegovy to reduce the risk of adverse cardiovascular events